{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:25:26Z","timestamp":1792783526710,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"CIBERESP Network Biomedical Research Center for Epidemiology and Public Health","award":["ESP22PI08"],"award-info":[{"award-number":["ESP22PI08"]}]},{"name":"Fundaci\u00f3 Instituci\u00f3 dels Centres de Recerca de Catalunya","id":[{"id":"https:\/\/ror.org\/01bkbaq61","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"DOI":"10.1007\/s40266-026-01340-7","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:08:07Z","timestamp":1791389287000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Benzodiazepine Prescription and Use in the Older Adults in Catalonia, Spain from 2018 to 2022: A Drug Utilization Study"],"prefix":"10.1007","author":[{"given":"Mili\u00e7a Paut","family":"Kusturica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Teresa","family":"Pe\u00f1arrubia-Mar\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy Anne","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mucherino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Menditto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6780-5968","authenticated-orcid":false,"given":"Ignacio","family":"Aznar Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"issue":"1","key":"1340_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-08984-z","volume":"20","author":"F Torres-Bondia","year":"2002","unstructured":"Torres-Bondia F, de Batlle J, Galv\u00e1n L, et al. Trends in the consumption rates of benzodiazepines and benzodiazepine-related drugs in the health region of Lleida from 2002 to 2015. BMC Public Health. 2002;20(1):818. https:\/\/doi.org\/10.1186\/s12889-020-08984-z.","journal-title":"BMC Public Health"},{"key":"1340_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-031156","volume":"10","author":"X Luta","year":"2020","unstructured":"Luta X, Bagnoud C, Lambiris M, et al. Patterns of benzodiazepine prescription among older adults in Switzerland: a cross-sectional analysis of claims data. BMJ Open. 2020;10:e031156. https:\/\/doi.org\/10.1136\/bmjopen-2019-031156.","journal-title":"BMJ Open"},{"key":"1340_CR3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/acps.12858","volume":"137","author":"P Verger","year":"2018","unstructured":"Verger P, Mmadi Mrenda B, Cortaredona S, et al. Trajectory analysis of anxiolytic dispensing over 10\u00a0years among new users aged 50 and older. Acta Psychiatr Scand. 2018;137:328\u201341. https:\/\/doi.org\/10.1111\/acps.12858.","journal-title":"Acta Psychiatr Scand"},{"key":"1340_CR4","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/pds.1344","volume":"16","author":"P Carrasco-Garrido","year":"2007","unstructured":"Carrasco-Garrido P, Jimenez-Garcia R, Astasio-Arbiza P, et al. Psychotropics use in the Spanish elderly: predictors and evolution between years 1993 and 2003. Pharmacoepidemiol Drug Saf. 2007;16:449\u201357. https:\/\/doi.org\/10.1002\/pds.1344.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1340_CR5","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.22374\/1710-6222.26.1.3","volume":"26","author":"J Brandt","year":"2001","unstructured":"Brandt J, Alessi-Severini S, Singer A, Leong C. Novel measures of benzodiazepine and Z-drug utilisation trends in a Canadian provincial adult population (2001\u20132016). J Popul Ther Clin Pharmacol. 2001;26:e22\u201338. https:\/\/doi.org\/10.22374\/1710-6222.26.1.3.","journal-title":"J Popul Ther Clin Pharmacol"},{"issue":"4","key":"1340_CR6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1753-6405.2007.00091.x","volume":"31","author":"A Windle","year":"2007","unstructured":"Windle A, Elliot E, Duszynski K, Moore V. Benzodiazepine prescribing in older adults Australian general practice patients. Aust N Z J Public Health. 2007;31(4):379\u201381. https:\/\/doi.org\/10.1111\/j.1753-6405.2007.00091.x.","journal-title":"Aust N Z J Public Health"},{"key":"1340_CR7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","volume":"72","author":"M Olfson","year":"2015","unstructured":"Olfson M, King M, Schoenbaum M. Benzodiazepine use in the United States. JAMA Psychiat. 2015;72:136\u201342. https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.1763.","journal-title":"JAMA Psychiat"},{"key":"1340_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-024-04742-7","volume":"24","author":"A Luka\u010di\u0161inov\u00e1","year":"2024","unstructured":"Luka\u010di\u0161inov\u00e1 A, Reissigov\u00e1 J, Ortner-Had\u017eiabdi\u0107 M, et al. Prevalence, country-specific prescribing patterns and determinants of benzodiazepine use in community-residing older adults in 7 European countries. BMC Geriatr. 2024;24:240. https:\/\/doi.org\/10.1186\/s12877-024-04742-7.","journal-title":"BMC Geriatr"},{"issue":"1","key":"1340_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2217\/nmt-2020-0056","volume":"11","author":"A Gupta","year":"2020","unstructured":"Gupta A, Bhattacharya G, Balaram K, Tampi D, Tampi RR. Benzodiazepine use among older adults. Neurodegener Dis Manag. 2020;11(1):5\u20138. https:\/\/doi.org\/10.2217\/nmt-2020-0056.","journal-title":"Neurodegener Dis Manag"},{"issue":"8","key":"1340_CR10","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.eurpsy.2015.09.003","volume":"30","author":"TA Kurko","year":"2015","unstructured":"Kurko TA, Saastamoinen LK, T\u00e4hk\u00e4p\u00e4\u00e4 S, et al. Long-term use of benzodiazepines: definitions, prevalence and usage patterns: a systematic review of register-based studies. Eur Psychiatry. 2015;30(8):1037\u201347. https:\/\/doi.org\/10.1016\/j.eurpsy.2015.09.003.","journal-title":"Eur Psychiatry"},{"issue":"5","key":"1340_CR11","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.genhosppsych.2006.05.008","volume":"28","author":"GE Simon","year":"2006","unstructured":"Simon GE, Ludman EJ. Outcome of new benzodiazepine prescriptions to older adults in primary care. Gen Hosp Psychiatry. 2006;28(5):374\u20138. https:\/\/doi.org\/10.1016\/j.genhosppsych.2006.05.008.","journal-title":"Gen Hosp Psychiatry"},{"issue":"12","key":"1340_CR12","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1111\/jgs.14379","volume":"64","author":"DT Maust","year":"2016","unstructured":"Maust DT, Kales HC, Wiechers IR, et al. No end in sight: benzodiazepine use in older adults in the United States. J Am Geriatr Soc. 2016;64(12):2546\u201353. https:\/\/doi.org\/10.1111\/jgs.14379.","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"1340_CR13","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1111\/jgs.12253","volume":"61","author":"MB Rothberg","year":"2013","unstructured":"Rothberg MB, Herzig SJ, Pekow PS, et al. Association between sedating medications and delirium in older inpatients. J Am Geriatr Soc. 2013;61(6):923\u201330. https:\/\/doi.org\/10.1111\/jgs.12253.","journal-title":"J Am Geriatr Soc"},{"key":"1340_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13101485","volume":"13","author":"CC Wu","year":"2023","unstructured":"Wu CC, Liao MH, Su CH, et al. Benzodiazepine use and the risk of dementia in the elderly population: an umbrella review of meta-analyses. J Pers Med. 2023;13:1485. https:\/\/doi.org\/10.3390\/jpm13101485.","journal-title":"J Pers Med"},{"key":"1340_CR15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s40268-017-0207-7","volume":"17","author":"J Brandt","year":"2017","unstructured":"Brandt J, Leong C. Benzodiazepines and Z-drugs: an updated review of major adverse outcomes reported on in epidemiologic research. Drugs R D. 2017;17:493\u2013507. https:\/\/doi.org\/10.1007\/s40268-017-0207-7.","journal-title":"Drugs R D"},{"issue":"1","key":"1340_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.rpsmen.2017.04.001","volume":"11","author":"M Martinez-Cengotitabengoa","year":"2018","unstructured":"Martinez-Cengotitabengoa M, Diaz-Gutierrez MJ, Besga A, et al. Benzodiazepine prescriptions and falls in older men and women. Rev Psiquiatr Salud Ment (Engl Ed). 2018;11(1):12\u20138. https:\/\/doi.org\/10.1016\/j.rpsmen.2017.04.001.","journal-title":"Rev Psiquiatr Salud Ment (Engl Ed)"},{"issue":"6","key":"1340_CR17","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1159\/000339095","volume":"58","author":"B Koechl","year":"2012","unstructured":"Koechl B, Unger A, Fischer G. Age-related aspects of addiction. Gerontology. 2012;58(6):540\u20134. https:\/\/doi.org\/10.1159\/000339095.","journal-title":"Gerontology"},{"key":"1340_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.11606\/s1518-8787.2022056003740","volume":"56","author":"MBO Freire","year":"2022","unstructured":"Freire MBO, Da Silva BGC, Bertoldi AD, et al. Benzodiazepines utilization in Brazilian older adults: a population-based study. Rev Saude Publica. 2022;56:10. https:\/\/doi.org\/10.11606\/s1518-8787.2022056003740.","journal-title":"Rev Saude Publica"},{"key":"1340_CR19","unstructured":"Gobierno Vasco, Departamento de Sanidad y Consumo. Gu\u00eda Farmacoterap\u00e9utica para los pacientes geri\u00e1tricos. Espa\u00f1a; 2012. https:\/\/www.osakidetza.euskadi.eus\/contenidos\/informacion\/publicaciones_informes_estudio\/es_pub\/adjuntos\/guia_pacientes_geriatricos.pdf. Accessed 31 May 2025."},{"key":"1340_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102507","volume":"70","author":"J Brandt","year":"2024","unstructured":"Brandt J, Bressi J, L\u00ea ML, Neal D, Cadogan C, Witt-Doerring J, et al. Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an international scoping review. EClinicalMedicine. 2024;70:102507. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102507.","journal-title":"EClinicalMedicine"},{"key":"1340_CR21","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.encep.2010.04.016","volume":"36","author":"M Bourin","year":"2010","unstructured":"Bourin M. The problems with the use of benzodiazepines in older adults patients. Enc\u00e9phale. 2010;36:340\u20137. https:\/\/doi.org\/10.1016\/j.encep.2010.04.016.","journal-title":"Enc\u00e9phale"},{"key":"1340_CR22","unstructured":"World Health Organization. WHO Expert Committee on Selection and Use of Essential Medicines: proposal to revise the indications for the use of benzodiazepine medicines in the treatment of anxiety disorders. World Health Organization, Geneva; 2023. https:\/\/www.who.int\/publications. Accessed 16 Sept 2026."},{"key":"1340_CR23","unstructured":"National Institute for Health and Care Excellence (NICE). Generalised anxiety disorder and panic disorder in adults: management. NICE guideline CG113 (updated 2020). London: NICE; 2011. https:\/\/www.nice.org.uk\/guidance\/cg113. Accessed 16 Sept 2026."},{"key":"1340_CR24","unstructured":"Spanish Agency for Medicines and Health Products. Circular 3\/2000: information that must appear in the data sheet of pharmaceutical specialties whose composition includes a benzodiazepine or analog (zolpidem, zopiclone), with the indication of anxiolytic and\/or hypnotic. https:\/\/www.sefh.es\/alertas\/alertas8.htm. Accessed 11 May 2025."},{"issue":"2","key":"1340_CR25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.clinthera.2024.12.003","volume":"47","author":"Z Yang","year":"2025","unstructured":"Yang Z, Shader RI, Greenblatt DJ. Time trends in prescribing of anxiolytic, sedative, and hypnotic drugs in the United States. Clin Ther. 2025;47(2):263\u201370.e3. https:\/\/doi.org\/10.1016\/j.clinthera.2024.12.003.","journal-title":"Clin Ther"},{"issue":"1","key":"1340_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-019-0969-9","volume":"20","author":"M Guisado-Clavero","year":"2019","unstructured":"Guisado-Clavero M, Viol\u00e1n C, L\u00f3pez-Jimenez T, et al. Medication patterns in older adults with multimorbidity: a cluster analysis of primary care patients. BMC Fam Pract. 2019;20(1):82. https:\/\/doi.org\/10.1186\/s12875-019-0969-9.","journal-title":"BMC Fam Pract"},{"key":"1340_CR27","unstructured":"Generalitat de Catalunya. Essencial: Tractament prolongat amb benzodiazepines en persones adultes amb trastorns d\u2019ansietat. GENCAT; 2016 (updated 2022). Barcelona. https:\/\/essencialsalut.gencat.cat\/ca\/detalls\/Article\/tractament_benzodiazepines_ansietat_adults. Accessed 16 Sept 2026."},{"issue":"8","key":"1340_CR28","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00228-023-03515-2","volume":"79","author":"K Isomura","year":"2023","unstructured":"Isomura K, Wang X, Chang Z, et al. Factors associated with long-term benzodiazepine and Z-drug use across the lifespan and 5-year temporal trajectories among incident users: a Swedish nationwide register-based study. Eur J Clin Pharmacol. 2023;79(8):1091\u2013105. https:\/\/doi.org\/10.1007\/s00228-023-03515-2.","journal-title":"Eur J Clin Pharmacol"},{"key":"1340_CR29","doi-asserted-by":"publisher","unstructured":"Garc\u00eda MAF, Olry de Labry Lima A, Ferrer Lopez I, et al. Analysis of changes in trends in the consumption rates of benzodiazepines and benzodiazepine-related drugs. J Pharm Policy Pract. 2018;1:1. https:\/\/doi.org\/10.1186\/s40545-017-0128-4.","DOI":"10.1186\/s40545-017-0128-4"},{"issue":"2","key":"1340_CR30","first-page":"1","volume":"20","author":"E Bernal-Delgado","year":"2018","unstructured":"Bernal-Delgado E, Garcia-Armesto S, Oliva J, et al. Spain: health system review. Health Syst Transit. 2018;20(2):1\u2013179.","journal-title":"Health Syst Transit"},{"key":"1340_CR31","unstructured":"Idescat. Population estimates. S1\/2025. Statistical Institute of Catalonia; 2025. https:\/\/www.idescat.cat. Accessed 10 July 2026."},{"issue":"6","key":"1340_CR32","doi-asserted-by":"publisher","first-page":"e324","DOI":"10.1093\/ije\/dyac068","volume":"51","author":"M Recalde","year":"2022","unstructured":"Recalde M, Rodr\u00edguez C, Burn E, Far M, et al. Data resource profile: the Information System for Research in Primary Care (SIDIAP). Int J Epidemiol. 2022;51(6):e324\u201336. https:\/\/doi.org\/10.1093\/ije\/dyac068.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"1340_CR33","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000524400","volume":"91","author":"SL Dubovsky","year":"2022","unstructured":"Dubovsky SL, Marshall D. Benzodiazepines remain important therapeutic options in psychiatric practice. Psychother Psychosom. 2022;91(5):307\u201334. https:\/\/doi.org\/10.1159\/000524400.","journal-title":"Psychother Psychosom"},{"issue":"4","key":"1340_CR34","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s41999-023-00777-y","volume":"14","author":"D O\u2019Mahony","year":"2023","unstructured":"O\u2019Mahony D, Cherubini A, Renom Guiteras A, et al. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med. 2023;14(4):625\u201332. https:\/\/doi.org\/10.1007\/s41999-023-00777-y.","journal-title":"Eur Geriatr Med"},{"key":"1340_CR35","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS). Nota informativa sobre el uso de benzodiacepinas en el tratamiento de la ansiedad y el insomnio. Ministerio de Sanidad y Consumo; 2000. https:\/\/www.aemps.gob.es\/medicamentosUsoHumano\/observatorio\/docs\/ansioliticos_hipnoticos.pdf. Accessed 31 May 2025."},{"issue":"1","key":"1340_CR36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/bcpt.13811","volume":"132","author":"M H\u00f8jlund","year":"2023","unstructured":"H\u00f8jlund M, Gudmundsson LS, Andersen JH, et al. Use of benzodiazepines and benzodiazepine-related drugs in the Nordic countries between 2000 and 2020. Basic Clin Pharmacol Toxicol. 2023;132(1):60\u201370. https:\/\/doi.org\/10.1111\/bcpt.13811.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"4","key":"1340_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.appr.2023.100183","volume":"5","author":"LM V\u00e1zquez Canales","year":"2023","unstructured":"V\u00e1zquez Canales LM, Fern\u00e1ndez MF. La prevenci\u00f3n cuaternaria en el uso de benzodiacepinas y c\u00f3mo deprescribirlas. Atenci\u00f3n Primaria Pr\u00e1ctica. 2023;5(4):100183. https:\/\/doi.org\/10.1016\/j.appr.2023.100183.","journal-title":"Atenci\u00f3n Primaria Pr\u00e1ctica"},{"issue":"4","key":"1340_CR38","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3390\/neurolint13040059","volume":"13","author":"AN Edinoff","year":"2021","unstructured":"Edinoff AN, Nix CA, Hollier J, et al. Benzodiazepines: uses, dangers, and clinical considerations. Neurol Int. 2021;13(4):594\u2013607. https:\/\/doi.org\/10.3390\/neurolint13040059.","journal-title":"Neurol Int"},{"issue":"2","key":"1340_CR39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s0212-6567(00)78472","volume":"25","author":"R Escriv\u00e1 Ferrair\u00f3","year":"2000","unstructured":"Escriv\u00e1 Ferrair\u00f3 R, P\u00e9rez D\u00edez A, Lumbreras Garc\u00eda C, et al. Prescripci\u00f3n de benzodiacepinas en un centro de salud: prevalencia, c\u00f3mo es su consumo y caracter\u00edsticas del consumidor [Benzodiazepine prescription at a health center: prevalence, its use and user characteristics]. Aten Primaria. 2000;25(2):107\u201310. https:\/\/doi.org\/10.1016\/s0212-6567(00)78472.","journal-title":"Aten Primaria"},{"issue":"2","key":"1340_CR40","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3109\/03602538308991391","volume":"14","author":"DJ Greenblatt","year":"1983","unstructured":"Greenblatt DJ, Divoll M, Abernethy DR, Ochs HR, Shader RI. Benzodiazepine kinetics: implications for therapeutics and pharmacogeriatrics. Drug Metab Rev. 1983;14(2):251\u201392. https:\/\/doi.org\/10.3109\/03602538308991391.","journal-title":"Drug Metab Rev"},{"issue":"19","key":"1340_CR41","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1056\/NEJM199305133281907","volume":"328","author":"RI Shader","year":"1993","unstructured":"Shader RI, Greenblatt DJ. Use of benzodiazepines in anxiety disorders. N Engl J Med. 1993;328(19):1398\u2013405. https:\/\/doi.org\/10.1056\/NEJM199305133281907.","journal-title":"N Engl J Med"},{"key":"1340_CR42","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1017\/S0714980812000232","volume":"31","author":"M Pr\u00e9ville","year":"2012","unstructured":"Pr\u00e9ville M, Boss\u00e9 C, Vasiliadis HM, et al. Correlates of potentially inappropriate prescriptions of benzodiazepines among older adults: results from the ESA study. Can J Aging. 2012;31:313\u201322. https:\/\/doi.org\/10.1017\/S0714980812000232.","journal-title":"Can J Aging"},{"issue":"2","key":"1340_CR43","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00127-011-0344-1","volume":"47","author":"CM Sonnenberg","year":"2012","unstructured":"Sonnenberg CM, Bierman EJ, Deeg DJ, et al. Ten-year trends in benzodiazepine use in the Dutch population. Soc Psychiatry Psychiatr Epidemiol. 2012;47(2):293\u2013301. https:\/\/doi.org\/10.1007\/s00127-011-0344-1.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"11","key":"1340_CR44","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1177\/09603271211013","volume":"40","author":"NL Michaels","year":"2021","unstructured":"Michaels NL, Spiller HA, Smith GA. Benzodiazepine exposures among women of reproductive age in the US, 2004\u20132018. Hum Exp Toxicol. 2021;40(11):1807\u201316. https:\/\/doi.org\/10.1177\/09603271211013.","journal-title":"Hum Exp Toxicol"},{"key":"1340_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2020.106608","volume":"112","author":"RK McHugh","year":"2021","unstructured":"McHugh RK, Geyer RB, Chase AR, et al. Gender differences in benzodiazepine misuse among adults with substance use disorders. Addict Behav. 2021;112:106608. https:\/\/doi.org\/10.1016\/j.addbeh.2020.106608.","journal-title":"Addict Behav"},{"issue":"1","key":"1340_CR46","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.7399","volume":"2","author":"SD Agarwal","year":"2019","unstructured":"Agarwal SD, Landon BE. Patterns in outpatient benzodiazepine prescribing in the United States. JAMA Netw Open. 2019;2(1):e187399. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.7399.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"1340_CR47","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00127-020-01989-4","volume":"56","author":"RS McIntyre","year":"2021","unstructured":"McIntyre RS, Chen VC, Lee Y, et al. The influence of prescriber and patient gender on the prescription of benzodiazepines: evidence for stereotypes and biases? Soc Psychiatry Psychiatr Epidemiol. 2021;56(6):1083\u20139. https:\/\/doi.org\/10.1007\/s00127-020-01989-4.","journal-title":"Soc Psychiatry Psychiatr Epidemiol."},{"issue":"3","key":"1340_CR48","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1176\/appi.ajp.20240030","volume":"181","author":"SB Soumerai","year":"2024","unstructured":"Soumerai SB, Shahzad M, Salzman C. Setting the record straight on long-term use, dose escalation, and potential misuse of prescription benzodiazepines. Am J Psychiatry. 2024;181(3):186\u20138. https:\/\/doi.org\/10.1176\/appi.ajp.20240030.","journal-title":"Am J Psychiatry"},{"key":"1340_CR49","doi-asserted-by":"publisher","unstructured":"Gerlach LB, Donovan T. Maust, MD, et al. Factors associated with long-term benzodiazepine use among older adults. JAMA Intern Med. 2018;178(11):1560\u20132. https:\/\/doi.org\/10.1001\/jamainternmed.2018.2413.","DOI":"10.1001\/jamainternmed.2018.2413"},{"issue":"3","key":"1340_CR50","doi-asserted-by":"publisher","DOI":"10.1136\/fmch-2024-003233","volume":"13","author":"MT Pe\u00f1arrubia-Mar\u00eda","year":"2025","unstructured":"Pe\u00f1arrubia-Mar\u00eda MT, Parker LA, Puig-Garc\u00eda M, Fuente-Moreno M, Lumbreras B, Lopez-Pintor E, et al. Challenge of long-term benzodiazepine use in primary care: insights from a real-world cohort study in Catalonia. Fam Med Community Health. 2025;13(3):e003233. https:\/\/doi.org\/10.1136\/fmch-2024-003233.","journal-title":"Fam Med Community Health"},{"key":"1340_CR51","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.psychres.2016.01.040","volume":"237","author":"N Takeshima","year":"2016","unstructured":"Takeshima N, Ogawa Y, Hayasaka Y, et al. Continuation and discontinuation of benzodiazepine prescriptions: a cohort study based on a large claims database in Japan. Psychiatry Res. 2016;237:201\u20137. https:\/\/doi.org\/10.1016\/j.psychres.2016.01.040.","journal-title":"Psychiatry Res"},{"issue":"3","key":"1340_CR52","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1192\/bjp.2020.164","volume":"218","author":"E Silberman","year":"2021","unstructured":"Silberman E, Balon R, Starcevic V, Shader R, Cosci F, Fava GA, et al. Benzodiazepines: it\u2019s time to return to the evidence. Br J Psychiatry. 2021;218(3):125\u20137. https:\/\/doi.org\/10.1192\/bjp.2020.164.","journal-title":"Br J Psychiatry"},{"key":"1340_CR53","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1007\/s11606-025-09499-2","volume":"40","author":"E Brunner","year":"2025","unstructured":"Brunner E, Chen CYA, Klein T, et al. Joint clinical practice guideline on benzodiazepine tapering: considerations when risks outweigh benefits. J Gen Intern Med. 2025;40:2814\u201359. https:\/\/doi.org\/10.1007\/s11606-025-09499-2.","journal-title":"J Gen Intern Med"},{"issue":"5","key":"1340_CR54","first-page":"339","volume":"64","author":"K Pottie","year":"2018","unstructured":"Pottie K, Thompson W, Davies S, Grenier J, Sadowski CA, Welch V, et al. Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline. Can Fam Physician. 2018;64(5):339\u201351.","journal-title":"Can Fam Physician"},{"key":"1340_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-024-05027-9","volume":"24","author":"O H\u00fcrlimann","year":"2024","unstructured":"H\u00fcrlimann O, Alers D, Hauri N, Leist P, Schneider C, Bolt L, et al. Barriers, facilitators and needs to deprescribe benzodiazepines and other sedatives in older adults: a mixed methods study of primary care provider perspectives. BMC Geriatr. 2024;24:396. https:\/\/doi.org\/10.1186\/s12877-024-05027-9.","journal-title":"BMC Geriatr"},{"issue":"3","key":"1340_CR56","doi-asserted-by":"publisher","first-page":"e2459883","DOI":"10.1001\/jamanetworkopen.2024.59883","volume":"8","author":"V Shapoval","year":"2025","unstructured":"Shapoval V, de Saint Hubert M, Evrard P, et al. Barriers to deprescribing benzodiazepines in older adults in a survey of European physicians. JAMA Netw Open. 2025;8(3):e2459883. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.59883.","journal-title":"JAMA Netw Open"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01340-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-026-01340-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01340-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:08:09Z","timestamp":1791389289000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-026-01340-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":56,"alternative-id":["1340"],"URL":"https:\/\/doi.org\/10.1007\/s40266-026-01340-7","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Mili\u00e7a Paut Kusturica, M. Teresa Pe\u00f1arrubia-Mar\u00eda, Lucy Anne Parker, Sara Mucherino, Enrica Menditto, Valentina Orlando, and Ignacio Aznar Lou have no conflicts of interest that are directly relevant to the content of this article.","order":1,"name":"Ethics","label":"Conflicts of Interest\/Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee at IDIAP Jordi Gol (22\/114-Eom).","order":2,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research team is not the data owner as they are only re-using information that is the property of public health institutions. The data that support the findings of this study are available from SIDIAP, but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of SIDIAP.","order":5,"name":"Ethics","label":"Availability of Data and Material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The code is available from the authors upon reasonable request.","order":6,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"IAL designed and supervised the study, conducted the data analysis, and interpreted the results. MPK interpreted the results and drafted the initial manuscript. MTPM assisted with the study design and interpretation of the data. All authors have read and approved the final version of the manusript.","order":7,"name":"Ethics","label":"Authors\u2019 Contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}